Search

everythinglearnresearchcommunity

for

Search:↓

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

The article suggests that patients with Frontal Fibrosing Alopecia may have more contact allergies, but it doesn't prove that allergies cause the condition.

Blood pressure drugs can cause skin lupus, early treatment is key for baby herpes and diabetic foot ulcers, a certain vaccine works against genital herpes and HPV in women, more frequent light therapy helps psoriasis, smoking and drinking can worsen psoriasis, a cream clears up a type of skin cancer, and low iron levels don't cause chronic hair loss.

Stopping certain drugs can improve skin conditions, arsenicosis affects over half of a Bangladeshi village, males are more vulnerable, and certain treatments are effective for warts, acne, and psoriasis. Smoking and drinking are linked to psoriasis in men, a cream helps with a type of skin cancer, and low iron levels don't directly cause chronic hair loss in women.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Wnt5a overexpression alone doesn't cause psoriasis in mice but affects hair growth.

Current skin substitutes help heal severe burns but don't fully replicate natural skin features.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Current methods can't fully recreate skin and its features, and more research is needed for clinical use.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.

Osteopontin may play a role in alopecia areata, but its levels don't predict treatment success.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

PRP or nanofat injections improve scar tissue quality but don't significantly boost hair transplant results for scarring hair loss.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Sentinel lymph node mapping is safe and effective for early-stage ovarian cancer but isn't yet standard practice.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.